HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


WEN Consumers To Begin Filing Claims Under Approved Class Settlement

This article was originally published in The Rose Sheet

Executive Summary

A class action settlement preliminarily approved in California’s Central District will establish a $26.25m fund for compensating WEN hair-care consumers for purchases and alleged injuries, but the fairness of payments to up to 6 million class members may have to be revisited if more claims are filed than expected. Notices to class members will issue by year-end, and their claims must be submitted by late April 2017.

You may also be interested in...

Monat Can’t Shed Class Action Linking Its Products To Hair Loss

Eighteen plaintiffs seeking nationwide class certification may proceed with their suit alleging that Monat hair-care products, deceptively advertised as anti-aging solutions, actually cause hair loss. A US district judge on 23 October largely denied Monat’s motion to dismiss, while noting that plaintiffs may have difficulty proving that the company’s products are to blame for their injuries.

Former FDA Commish Califf Advocates Cosmetics Registration, AE Reporting

FDA is hampered in its public safety mission under current law, which does not require cosmetics firms to register marketed products or report adverse events, former agency head Robert Califf says. His June 26 editorial in Jama Internal Medicine accompanies an analysis of FDA's cosmetics adverse-event data.

L’Oreal Hair-Relaxer Class Action A Far Cry From WEN, Or Next Plaintiff Payout?

Putative class actions against L’Oreal alleging that a Soft Sheen-Carson hair relaxer causes hair loss and scalp irritation have been consolidated in New York’s Southern District. Similar to complaints targeting WEN in recent years, the L’Oreal suits cite “an inherent design and/or manufacturing defect,” but L’Oreal says it provides ample warning of risks on product packaging and the category represents known hazards.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts